cache/0ad971dfb438c97b4816933a9753dd140f8e65252c77820f564e949aa2e1ec8d

COM:AVOPLC

Advanced Oncotherapy Plc

  • Stock

Last Close

1.93

30/08 15:23

Market Cap

94.95K

Beta: -

Volume Today

16.20M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
18.60K
-
574.62K
2,989.46%
2.77M
381.21%
5.93M
114.38%
7.53M
27.08%
8.82M
17.10%
12.53M
42.05%
18.59M
48.38%
23.98M
28.98%
12.91M
46.16%
average payables
2.08M
-
2.27M
8.97%
2.40M
5.78%
2.80M
16.40%
5.31M
89.97%
6.72M
26.54%
5.42M
19.41%
5.66M
4.46%
5.89M
4.12%
2.67M
54.63%
average receivables
2.41M
-
2.41M
0%
112.51K
-
book value per share
0.33
-
0.33
1.78%
0.53
62.55%
0.56
4.85%
0.37
34.13%
0.23
38.68%
0.20
10.10%
0.15
24.76%
0.16
5.04%
capex per share
-0.05
-
-0.04
15.20%
-0.08
116.91%
-0.16
89.91%
-0.11
30.91%
-0.08
26.97%
-0.06
29.35%
-0.03
54.65%
-0.02
5.59%
capex to depreciation
-8.88
-
-11.15
25.62%
-127.05
1,039.46%
-28.02
77.94%
-23.42
16.42%
-29.41
25.57%
-5.93
79.85%
-3.19
46.17%
-3.97
24.56%
capex to operating cash flow
0.25
-
0.20
19.75%
0.44
117.84%
0.89
103.29%
0.89
0.85%
7.26
713.29%
0.51
92.98%
0.37
27.89%
0.31
14.46%
capex to revenue
-10.62
-
-12.33
16.05%
cash per share
0.01
-
0.04
366.12%
0.18
305.56%
0.02
86.39%
0.00
96.95%
0.01
827.35%
0.02
127.33%
0.01
47.58%
0.01
38.90%
days of inventory on hand
87.06
-
2.00K
2,200.25%
1.91K
-
days payables outstanding
5.14K
-
4.23K
17.79%
1.14K
-
days sales outstanding
debt to assets
0.30
-
0.07
76.99%
0.03
52.36%
0.01
55.67%
0.20
1,312.38%
0.05
75.22%
0.42
731.60%
0.41
1.34%
0.38
8.79%
debt to equity
0.59
-
0.09
85.08%
0.04
58.69%
0.02
56.40%
0.32
1,918.80%
0.09
72.65%
1.08
1,127.43%
1.15
5.90%
0.87
24.21%
dividend yield
earnings yield
-0.30
-
-0.22
27.63%
-0.06
71.32%
-0.23
257.31%
-0.30
31.98%
-0.35
19.32%
-0.25
30.74%
-0.29
18.61%
-0.24
16.82%
enterprise value
15.99M
-
33.46M
109.19%
95.96M
186.81%
45.00M
53.11%
55.11M
22.48%
61.45M
11.50%
127.86M
108.07%
152.35M
19.15%
194.44M
27.62%
enterprise value over ebitda
-7.83
-
-6.65
15.15%
-12.70
91.01%
-3.53
72.17%
-3.90
10.39%
-2.87
26.31%
-6.87
138.88%
-8.49
23.69%
-9.09
6.97%
ev to operating cash flow
-5.44
-
-5.10
6.28%
-9.75
91.07%
-4.12
57.76%
-5.75
39.65%
-36.91
541.95%
-5.43
85.29%
-7.53
38.64%
-6.58
12.63%
ev to sales
232.08
-
314.52
35.52%
free cash flow per share
-0.23
-
-0.23
1.50%
-0.28
19.12%
-0.34
22.70%
-0.23
31.22%
-0.09
60.80%
-0.17
83.97%
-0.10
43.03%
-0.10
6.08%
free cash flow yield
-0.28
-
-0.23
18.16%
-0.14
41.35%
-0.45
230.11%
-0.40
11.98%
-0.23
41.45%
-0.42
81.67%
-0.27
36.70%
-0.27
0.50%
graham net net
-0.32
-
-0.04
88.09%
0.15
489.44%
0.02
83.74%
-0.12
585.37%
-0.13
8.55%
-0.27
109.25%
-0.22
17.04%
-0.16
26.80%
graham number
1.36
-
1.27
6.11%
1.24
2.68%
1.46
18.01%
1.21
17.58%
0.84
30.01%
0.67
20.59%
0.60
10.38%
0.58
3.97%
income quality
0.86
-
1.04
20.97%
1.68
62.58%
1.05
37.40%
0.70
33.45%
0.08
88.76%
1.13
1,335.96%
0.80
29.36%
1.00
25.31%
intangibles to total assets
0.62
-
0.64
2.40%
0.41
34.94%
0.62
49.54%
0.67
8.61%
0.68
0.34%
0.44
34.31%
0.47
4.78%
0.49
4.37%
0
100%
interest coverage
-12.31
-
-17.11
38.99%
-56.27
228.89%
-123.07
118.73%
-7.26
94.10%
-271.86
3,642.13%
-16.75
93.84%
-4.03
75.95%
-4.12
2.39%
interest debt per share
0.21
-
0.04
81.26%
0.02
44.06%
0.01
52.52%
0.14
1,251.91%
0.02
85.83%
0.23
1,003.29%
0.19
14.67%
0.15
19.77%
inventory turnover
4.19
-
0.18
95.65%
0.19
-
invested capital
0.59
-
0.09
85.08%
0.04
58.69%
0.02
56.40%
0.32
1,918.80%
0.09
72.65%
1.08
1,127.43%
1.15
5.90%
0.87
24.21%
market cap
12.95M
-
33.94M
162.00%
103.92M
206.23%
45.90M
55.83%
45.92M
0.04%
59.46M
29.49%
84.59M
42.26%
104.03M
22.98%
145.34M
39.71%
net current asset value
-4.00M
-
-165.21K
95.87%
13.22M
8,104.08%
8.86M
32.97%
-4.24M
147.81%
-11.78M
177.90%
-45.69M
287.99%
-51.81M
13.38%
-49.19M
5.06%
net debt to ebitda
-1.49
-
0.09
106.37%
1.05
1,010.38%
0.07
93.25%
-0.65
1,015.05%
-0.09
85.71%
-2.32
2,400.19%
-2.69
15.92%
-2.29
14.83%
net income per share
-0.25
-
-0.22
10.24%
-0.13
41.74%
-0.17
32.81%
-0.18
3.13%
-0.14
20.12%
-0.10
29.87%
-0.10
6.75%
-0.09
12.20%
operating cash flow per share
-0.18
-
-0.19
5.66%
-0.19
0.43%
-0.18
6.58%
-0.12
31.49%
-0.01
91.02%
-0.11
907.07%
-0.07
37.11%
-0.08
10.37%
payables turnover
0.07
-
0.09
21.65%
0.32
-
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-0.97
-
-1.42
46.73%
-0.36
74.38%
-0.72
98.40%
-0.92
27.44%
-1.09
18.82%
-0.34
69.18%
-0.46
37.43%
-0.48
4.56%
revenue per share
0.00
-
0.00
26.93%
roe
-0.73
-
-0.67
8.62%
-0.24
64.16%
-0.30
26.66%
-0.48
56.58%
-0.62
30.27%
-0.48
21.99%
-0.69
41.88%
-0.57
16.41%
roic
-0.54
-
-0.70
28.99%
-0.20
70.70%
-0.30
46.26%
-0.32
6.31%
-0.57
79.57%
-0.16
71.72%
-0.19
18.86%
-0.19
0.48%
sales general and administrative to revenue
29.56
-
52.21
76.63%
shareholders equity per share
0.33
-
0.33
1.78%
0.53
62.55%
0.56
4.85%
0.37
34.13%
0.23
38.68%
0.20
10.10%
0.15
24.76%
0.16
5.04%
stock based compensation to revenue
0.44
-
5.10
1,055.45%
tangible asset value
-1.33M
-
1.91M
244.45%
14.54M
659.45%
10.64M
26.82%
-1.91M
117.94%
-6.17M
223.33%
-6.25M
1.28%
-12.73M
103.69%
-7.21M
43.37%
tangible book value per share
-0.08
-
0.06
168.38%
0.28
403.75%
0.17
38.42%
-0.02
114.01%
-0.04
67.17%
-0.03
27.91%
-0.04
49.06%
-0.02
57.21%
working capital
-4.00M
-
-165.21K
95.87%
13.22M
8,104.08%
8.86M
32.97%
-4.24M
147.81%
4.72M
211.44%
15.72M
232.78%
7.13M
54.62%
14.61M
104.90%

All numbers in (except ratios and percentages)